# Management of adverse events associated with tyrosine kinase inhibitors: Improving outcomes for patients with hepatocellular carcinoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/management-of-adverse-events-associated-with-tyrosine-kinase-inhibitors/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Lorenza Rimassa,Romano Danesi,Tiziana Pressiani,Philippe Merle |
| Citations | 237 |
| DOI | 10.1016/j.ctrv.2019.05.004 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | http://www.cancertreatmentreviews.com/article/S0305737219300672/pdf |
| OpenAlex ID | https://openalex.org/W2945730831 |
| PMID | 31195212 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Romano Danesi](https://scholariq.org/researchers/romano-danesi/)

## Paper primary topic

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)

## Paper topics

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.